Illustration shows vials labelled “VACCINE Coronavirus COVID-19” and a syringe in front of a displayed Novavax logo
(Reuters) – Takeda Pharmaceutical Co Ltd has submitted an approval request for Novavax’s COVID-19 vaccine to Japan’s health ministry, the U.S. drugmaker said late on Wednesday.
(Reporting by Shivam Patel in Bengaluru; Editing by Sriraj Kalluvila)